Oral vs Intravenous Acetominophen for Postoperative Pain in Minimally Invasive Gynecologic Surgery
Preemptive Oral vs Intravenous Acetominophen for Postoperative Pain in Minimally Invasive Gynecologic Surgery: A Randomized Control Trial
Sponsor: Scripps Health
This NA trial investigates Post-operative Pain and is currently completed. Scripps Health leads this study, which shows 8 recorded versions since 2016 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Dec 2022 — Jul 2024 [monthly]
Completed NA
-
Jun 2022 — Dec 2022 [monthly]
Completed NA
Status: Unknown Status → Completed
-
Jan 2021 — Jun 2022 [monthly]
Unknown Status NA
▶ Show 3 earlier versions
-
Jan 2020 — Jan 2021 [monthly]
Unknown Status NA
Status: Enrolling By Invitation → Unknown Status
-
Jun 2018 — Jan 2020 [monthly]
Enrolling By Invitation NA
-
Jan 2018 — Jun 2018 [monthly]
Enrolling By Invitation NA
First recorded
Feb 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Scripps Health
For direct contact, visit the study record on ClinicalTrials.gov .